HRTX FY 2020 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$89M-39.3% YoY

Gross Profit

$52M59.2% margin

Operating Income

-$228M-257.4% margin

Net Income

-$227M-256.4% margin

EPS (Diluted)

$-2.50

Cash Flow

Operating Cash Flow

-$185M

Free Cash Flow

-$192M

Stock-Based Comp.

$50M

Balance Sheet

Total Assets

$354M

Total Liabilities

$117M

Stockholders' Equity

$236M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$146M	-39.3%
Gross Profit	$52M	$84M	-37.8%
Operating Income	-$228M	-$211M	-8.3%
Net Income	-$227M	-$205M	-11.0%